Bi Asset Management Fondsmaeglerselskab A Legend Biotech Corp Transaction History

Bi Asset Management Fondsmaeglerselskab A

  • $6.11 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
SELL
$55.06 - $69.99 $840,766 - $1.07 Million
-15,270 Reduced 82.15%
3,318 $186,000
Q4 2023

Feb 09, 2024
BUY
$57.25 - $69.74 $107,515 - $130,971
1,878 Added 11.24%
18,588 $1.12 Million
Q3 2023

Nov 13, 2023
BUY
$63.16 - $76.5 $1.06 Million - $1.28 Million
16,710 New
16,710 $1.12 Million

Others Institutions Holding LEGN

# of Institutions
198
Shares Held
74.2M
Call Options Held
374K
Put Options Held
387K
View Full List

About Legend Biotech Corp

LEGN Quotes by TradingView
  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $8.25B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Bi Asset Management Fondsmaeglerselskab A Portfolio

Follow Bi Asset Management Fondsmaeglerselskab A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email